Kayte Andersen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Back to Healio We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio It is only natural that individuals taking immunosuppressive medications would fear COVID-19. However, recent findings add to a growing body of data indicating that immunosuppression may not elevate risk for worse outcomes for COVID-19 hospitalization. “This is a small amount of good news at a time in this pandemic when we need it,” G. Caleb Alexander, MD, MS , told H ealio Rheumatology. “Doctors and patient...

New research suggests immunosuppressants do not increase the risk of worse COVID-19 outcomes.&nbsp;<br /> <br /> &nbsp;

Study suggests immunosuppressive drugs do not contribute to severity of COVID-19 Findings contribute to a growing body of evidence that may provide reassurance to clinicians and patients using chronic immunosuppressive medications By Bloomberg School of Public Health staff report / Published Jan 13, 2021 People taking immunosuppressive drugs to prevent organ transplant rejection or to treat inflammatory or autoimmune diseases do not fare worse than others on average when they are hospitalized with COVID-19, according to a new study from researchers at...

New research suggests immunosuppressants do not increase the risk of COVID-19.&nbsp;

Patients taking immunosuppressive drugs did not have worse COVID-19 outcomes People taking immunosuppressive drugs to prevent organ transplant rejection or to treat inflammatory or autoimmune diseases do not fare worse than others on average when they are hospitalized with COVID-19, according to a study from researchers at the Johns Hopkins Bloomberg School of Public Health. Estimates suggest that there are approximately 10 million immunocompromised people in the U.S. alone. Suppression of the immune system has been considered a potentially major risk factor for severe and fatal COVID-19 beca...